Biotech News

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

Veradigm (MDRX)Veradigm2026-06-25 13:46 ESTCompany update

CHICAGO --(BUSINESS WIRE)--Feb. 13, 2026-- Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence

Open original release

Related news

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Extends Stockholder Rights Plan

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Provides Business and Strategy Update

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

View all latest news

Veradigm

Veradigm is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MDRXVeradigm2026-06-26 12:45 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-06-26 12:45 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-26 12:45 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-26 12:45 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-26 12:45 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States